Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGF-1 and Bone Loss in Women Anorexia Nervosa
NCT00089843Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2003
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Testosterone TEPI patch and risedronate in anorexia nervosa (AN) (4 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Bone Mineral Density at 12 months. Started Jun 2003; status: completed.
02
Drugs
Testosterone TEPI patchrisedronate
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT00089843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089843.